SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Welcure Drugs & Pharmaceuticals informs about newspaper publication

21 May 2020 Evaluate

Welcure Drugs & Pharmaceuticals has informed that in terms of Circular no. 20/2020 dated May 5, 2020 issued by Ministry of Corporate Affairs read with Regulation 47 of SEBI (Listing Obligations and Disclosure Requirements) Regulation, 2015, the Company enclosed copies of Public notice regarding convening of 28th Annual General Meeting (AGM) through video conferencing, Book Closure and E-voting related procedure of the Company published in newspapers, The Financial Express (English Newspaper) & JanSatta (Hindi Newspaper) on Thursday, May 21, 2020.

The above information is a part of company’s filings submitted to BSE.

 

Welcure Drugs&Pharma Share Price

0.32 -0.01 (-3.03%)
17-Apr-2026 16:59 View Price Chart
Peers
Company Name CMP
Redington 234.90
Adani Enterprises 2218.35
Amrapali Industries 17.53
Rashi Peripheral 455.25
PDS 301.45
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×